The Johnson & Johnson Vaccine Pause and the Media’s Role in Communicating Risk

Early yesterday, the Food and Drug Administration and the Centers for Disease Control and Prevention recommended that the US pause distribution of Johnson & Johnson’s coronavirus vaccine following reports of blood clotting in six recipients, all of them women aged between eighteen and forty-eight, one of whom has died and another of whom is critically ill.

Click here to read more.